Activation of Wnt and Myc signaling in hepatoblastoma

Frontiers in Bioscience - Elite

Volumn 4 E, Issue 1, 2012, Pages 480-486

  Cairo, Stefano ^a   Armengol, Carolina ^b   Buendia, Marie Annick ^c  

^a XenTech   (France)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c INSTITUT PASTEUR   (France)

Author keywords

Beta Catenin; Cancer; Genomics; Liver; Molecular Biology; Myc; Pediatric; Proteomics; Review

Indexed keywords

AXIN; BETA CATENIN; BONE MORPHOGENETIC PROTEIN 4; CYCLIN D1; CYTOKERATIN 1; EPITHELIAL CELL ADHESION MOLECULE; FRIZZLED PROTEIN; GLYCOGEN SYNTHASE KINASE 3; HEAT SHOCK PROTEIN 27; I KAPPA B ALPHA; MELANOMA ANTIGEN; MYC PROTEIN; S6 KINASE; STAT6 PROTEIN; T CELL FACTOR PROTEIN; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEIN;

APOPTOSIS; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CHILDHOOD CANCER; COLON POLYPOSIS; FAMILIAL COLON POLYPOSIS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; HEPATOBLASTOMA; HUMAN; LOSS OF FUNCTION MUTATION; MALIGNANT TRANSFORMATION; MISSENSE MUTATION; MOLECULAR PATHOLOGY; MUTATION; NONHUMAN; PHENOTYPE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RNA TRANSLATION; STEM CELL; UPREGULATION; WNT SIGNALING PATHWAY; GENETICS; LIVER TUMOR; METABOLISM; REVIEW; SIGNAL TRANSDUCTION;

BETA CATENIN; HEPATOBLASTOMA; HUMANS; LIVER NEOPLASMS; MUTATION; PROTO-ONCOGENE PROTEINS C-MYC; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 84860853506     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: 10.2741/393     Document Type: Article

References (58)

1. P. J. Scotting, D. A. Walker, G. Perilongo: Childhood solid tumours: a developmental disorder. Nat Rev Cancer 5, 481-8 (2005)
2. A. G. Weinberg, M. J. Finegold: Primary hepatic tumors of childhood. Hum Pathol 14, 512-37 (1983)
3. J. M. Schnater, S. E. Kohler, W. H. Lamers, D. von Schweinitz, D. C. Aronson: Where do we stand with hepatoblastoma? A review. Cancer 98, 668-78 (2003)
4. A. Zimmermann: The emerging family of hepatoblastoma tumours: from ontogenesis to oncogenesis. Eur J Cancer 41, 1503-14 (2005)
5. A. Koch, D. Denkhaus, S. Albrecht, I. Leuschner, D. von Schweinitz, T. Pietsch: Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the b-catenin gene. Cancer Res 59, 269-273 (1999)
6. Y. Wei, M. Fabre, S. Branchereau, F. Gauthier, G. Perilongo, M. A. Buendia: Activation of beta-catenin in epithelial and mesenchymal hepatoblastomas. Oncogene 19, 498-504 (2000)
7. B. T. MacDonald, K. Tamai, X. He: Wnt/beta-Catenin Signaling: Components, Mechanisms, and Diseases Dev Cell 17, 9-26 (2009)
8. S. Cairo, C. Armengol, A. De Reynies, Y. Wei, E. Thomas, C. A. Renard, A. Goga, A. Balakrishnan, M. Semeraro, L. Gresh, M. Pontoglio, H. Strick-Marchand, F. Levillayer, Y. Nouet, D. Rickman, F. Gauthier, S. Branchereau, L. Brugieres, V. Laithier, R. Bouvier, F. Boman, G. Basso, J. F. Michiels, P. Hofman, F. Arbez-Gindre, H. Jouan, M. C. Rousselet-Chapeau, D. Berrebi, L. Marcellin, F. Plenat, D. Zachar, M. Joubert, J. Selves, D. Pasquier, P. Bioulac-Sage, M. Grotzer, M. Childs, M. Fabre, M. A. Buendia: Hepatic stem-like phenotype and interplay of Wnt/beta-catenin and Myc signaling in aggressive childhood liver cancer. Cancer Cell 14, 471-84 (2008)
9. A. M. Adesina, D. Lopez-Terrada, K. K. Wong, P. Gunaratne, Y. Nguyen, J. Pulliam, J. Margolin, M. J. Finegold: Gene expression profiling reveals signatures characterizing histologic subtypes of hepatoblastoma and global deregulation in cell growth and survival pathways. Hum Pathol 40, 843-53 (2009)
10. K. M. Cadigan, R. Nusse: Wnt signaling: a common theme in anaimal development. Genes Dev 11, 3286-3305 (1997)
11. H. Clevers: Wnt/beta-catenin signaling in development and disease. Cell 127, 469-80 (2006)
12. V. Korinek, N. Barker, P. J. Morin, D. van Wichen, R. de Weger, K. W. Kinzler, B. Vogelstein, H. Clevers: Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 275, 1784-7 (1997)
13. B. Rubinfeld, I. Albert, E. Porfiri, C. Fiol, S. Munemitsu, P. Polakis: Binding of GSK3β to the APC-β-catenin complex and regulation of complex assembly. Science 272, 1023-1026 (1996)
14. S. P. Monga, H. K. Monga, X. Tan, K. Mule, P. Pediaditakis, G. K. Michalopoulos: Beta-catenin antisense studies in embryonic liver cultures: role in proliferation, apoptosis, and lineage specification. Gastroenterology 124, 202-16 (2003)
15. S. Benhamouche, T. Decaens, C. Godard, R. Chambrey, D. S. Rickman, C. Moinard, M. Vasseur-Cognet, C. J. Kuo, A. Kahn, C. Perret, S. Colnot: Apc tumor suppressor gene is the "zonation-keeper" of mouse liver. Dev Cell 10, 759-70 (2006)
16. C. Cavard, S. Colnot, V. Audard, S. Benhamouche, L. Finzi, C. Torre, G. Grimber, C. Godard, B. Terris, C. Perret: Wnt/beta-catenin pathway in hepatocellular carcinoma pathogenesis and liver physiology. Future Oncol 4, 647-60 (2008)
17. R. H. Giles, J. H. van Es, H. Clevers: Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta 1653, 1-24 (2003)
18. P. Polakis: The many ways of Wnt in cancer. Curr Opin Genet Dev, 17, 45-51 (2007)
19. M. A. Buendia: Genetics of Hepatocellular Carcinoma. Semin Cancer Biol 10, 185-200 (2000)
20. J. Zucman-Rossi, E. Jeannot, J. Tran Van Nhieu, J. Y. Scoazec, C. Guettier, S. Rebouissou, Y. Bacq, E. Leteurtre, V. Paradis, S. Michalak, D. Wendum, L. Chiche, M. Fabre, L. Mellottee, C. Laurent, C. Partensky, D. Castaing, E. S. Zafrani, P. Laurent-Puig, C. Balabaud, P. Bioulac-Sage: Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology 43, 515-24 (2006)
21. A. de La Coste, B. Romagnolo, P. Billuart, C. A. Renard, M. A. Buendia, O. Soubrane, M. Fabre, J. Chelly, C. Beldjord, A. Kahn, C. Perret: Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci U S A 95, 8847-51 (1998)
22. S. Satoh, Y. Daigo, Y. Furukawa, T. Kato, N. Miwa, T. Nishiwaki, T. Kawasoe, H. Ishiguro, M. Fujita, T. Tokino, Y. Sasaki, S. Imaoka, M. Murata, T. Shimano, Y. Yamaoka, Y. Nakamura: AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet 24, 245-250 (2000)
23. A. Cadoret, C. Ovejero, S. Saadi-Kheddouci, E. Souil, M. Fabre, B. Romagnolo, A. Kahn, C. Perret: Hepatomegaly in transgenic mice expressing an oncogenic form of beta-catenin. Cancer Res 61, 3245-9. (2001)
24. S. Colnot, T. Decaens, M. Niwa-Kawakita, C. Godard, G. Hamard, A. Kahn, M. Giovannini, C. Perret: Livertargeted disruption of Apc in mice activates beta-catenin signaling and leads to hepatocellular carcinomas. Proc Natl Acad Sci U S A 101, 17216-21 (2004)
25. H. Blaker, W. J. Hofmann, R. J. Rieker, R. Penzel, M. Graf, H. F. Otto: Beta-catenin accumulation and mutation of the CTNNB1 gene in hepatoblastoma. Genes Chromosomes Cancer 25, 399-402 (1999)
26. Y. M. Jeng, M. Z. Wu, T. L. Mao, M. H. Chang, H. C. Hsu: Somatic mutations of beta-catenin play a crucial role in the tumorigenesis of sporadic hepatoblastoma. Cancer Lett 152, 45-51. (2000)
27. H. Takayasu, H. Horie, E. Hiyama, T. Matsunaga, Y. Hayashi, Y. Watanabe, S. Suita, M. Kaneko, F. Sasaki, K. Hashizume, T. Ozaki, K. Furuuchi, M. Tada, N. Ohnuma, A. Nakagawara: Frequent deletions and mutations of the beta-catenin gene are associated with overexpression of cyclin D1 and fibronectin and poorly differentiated histology in childhood hepatoblastoma. Clin Cancer Res 7, 901-8 (2001)
28. K. Taniguchi, L. R. Roberts, I. N. Aderca, X. Dong, C. Qian, L. M. Murphy, D. M. Nagorney, L. J. Burgart, P. C. Roche, D. I. Smith, J. A. Ross, W. Liu: Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Oncogene 21, 4863-71 (2002)
29. A. Koch, N. Weber, A. Waha, W. Hartmann, D. Denkhaus, J. Behrens, W. Birchmeier, D. von Schweinitz, T. Pietsch: Mutations and elevated transcriptional activity of conductin (AXIN2) in hepatoblastomas. J Pathol 204, 546-54 (2004)
30. H. Kurahashi, K. Takami, T. Oue, T. Kusafuka, A. Okada, A. Tawa, S. Okada, I. Nishisho: Biallelic inactivation of the APC gene in hepatoblastoma. Cancer Res 55, 5007-11 (1995)
31. S. Aretz, A. Koch, S. Uhlhaas, W. Friedl, P. Propping, D. von Schweinitz, T. Pietsch: Should children at risk for familial adenomatous polyposis be screened for hepatoblastoma and children with apparently sporadic hepatoblastoma be screened for APC germline mutations? Pediatr Blood Cancer 47, 811-818 (2006)
32. K. R. Reed, D. Athineos, V. S. Meniel, J. A. Wilkins, R. A. Ridgway, Z. D. Burke, V. Muncan, A. R. Clarke, O. J. Sansom: B-catenin deficiency, but not Myc deletion, suppresses the immediate phenotypes of APC loss in the liver. Proc Natl Acad Sci U S A 105, 18919-23 (2008)
33. H. Kim, E. K. Ham, Y. I. Kim, J. G. Chi, H. S. Lee, S. H. Park, Y. M. Jung, N. K. Myung, M. J. Lee, J. J. Jang: Overexpression of cyclin D1 and cdk4 in tumorigenesis of sporadic hepatoblastomas. Cancer Lett 131, 177-83 (1998)
34. C. A. Renard, C. Labalette, C. Armengol, D. Cougot, Y. Wei, S. Cairo, P. Pineau, C. Neuveut, A. de Reynies, A. Dejean, C. Perret, M. A. Buendia: Tbx3 Is a Downstream Target of the Wnt/ß-Catenin Pathway and a Critical Mediator of ß-Catenin Survival Functions in Liver Cancer. Cancer Res 67, 901-10 (2007)
35. O. Wirths, A. Waha, S. Weggen, P. Schirmacher, T. Kuhne, C. G. Goodyer, S. Albrecht, D. Von Schweinitz, T. Pietsch: Overexpression of human Dickkopf-1, an antagonist of wingless/WNT signaling, in human hepatoblastomas and Wilms' tumors. Lab Invest 83, 429-34 (2003)
36. S. Hailfinger, M. Jaworski, A. Braeuning, A. Buchmann, M. Schwarz: Zonal gene expression in murine liver: lessons from tumors. Hepatology 43, 407-14 (2006)
37. S. Boyault, D. S. Rickman, A. de Reynies, C. Balabaud, S. Rebouissou, E. Jeannot, A. Herault, J. Saric, J. Belghiti, D. Franco, P. Bioulac-Sage, P. Laurent-Puig, J. Zucman-Rossi: Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets. Hepatology 45, 42-52 (2007)
38. X. Wu, X. Tu, K. S. Joeng, M. J. Hilton, D. A. Williams, F. Long: Rac1 activation controls nuclear localization of betacatenin during canonical Wnt signaling. Cell 133, 340-53 (2008)
39. T. Nagata, Y. Takahashi, Y. Ishii, S. Asai, Y. Nishida, A. Murata, T. Koshinaga, M. Fukuzawa, M. Hamazaki, K. Asami, E. Ito, H. Ikeda, H. Takamatsu, K. Koike, A. Kikuta, M. Kuroiwa, A. Watanabe, Y. Kosaka, H. Fujita, M. Miyake, H. Mugishima: Transcriptional profiling in hepatoblastomas using high-density oligonucleotide DNA array. Cancer Genet Cytogenet 145, 152-60 (2003)
40. J. H. Luo, B. Ren, S. Keryanov, G. C. Tseng, U. N. Rao, S. P. Monga, S. Strom, A. J. Demetris, M. Nalesnik, Y. P. Yu, S. Ranganathan, G. K. Michalopoulos: Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas. Hepatology 44, 1012-24 (2006)
41. M. Vita, M. Henriksson: The Myc oncoprotein as a therapeutic target for human cancer. Semin Cancer Biol 16, 318-30 (2006)
42. V. Strieder, W. Lutz: Regulation of N-myc expression in development and disease. Cancer Lett 180, 107-19 (2002)
43. K. Pardali, A. Moustakas: Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer. Biochim Biophys Acta 1775, 21-62 (2007)
44. T. Sasaki, H. Suzuki, K. Yagi, M. Furuhashi, R. Yao, S. Susa, T. Noda, Y. Arai, K. Miyazono, M. Kato: Lymphoid enhancer factor 1 makes cells resistant to transforming growth factor beta-induced repression of c-myc. Cancer Res 63, 801-6 (2003)
45. E. Labbe, A. Letamendia, L. Attisano: Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways. Proc Natl Acad Sci U S A 97, 8358-63 (2000)
46. M. Nishita, M. K. Hashimoto, S. Ogata, M. N. Laurent, N. Ueno, H. Shibuya, K. W. Cho: Interaction between Wnt and TGF-beta signalling pathways during formation of Spemann's organizer. Nature 403, 781-5 (2000)
47. M. Lepourcelet, Y. N. Chen, D. S. France, H. Wang, P. Crews, F. Petersen, C. Bruseo, A. W. Wood, R. A. Shivdasani: Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex. Cancer Cell 5, 5-6 (2004)
48. N. Janssens, M. Janicot, T. Perera: The Wnt-dependent signaling pathways as target in oncology drug discovery. Invest New Drugs 24, 263-80 (2006)
49. S. M. Huang, Y. M. Mishina, S. Liu, A. Cheung, F. Stegmeier, G. A. Michaud, O. Charlat, E. Wiellette, Y. Zhang, S. Wiessner, M. Hild, X. Shi, C. J. Wilson, C. Mickanin, V. Myer, A. Fazal, R. Tomlinson, F. Serluca, W. Shao, H. Cheng, M. Shultz, C. Rau, M. Schirle, J. Schlegl, S. Ghidelli, S. Fawell, C. Lu, D. Curtis, M. W. Kirschner, C. Lengauer, P. M. Finan, J. A. Tallarico, T. Bouwmeester, J. A. Porter, A. Bauer, F. Cong: Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature 461, 614-20 (2009)
50. T. Noda, H. Nagano, I. Takemasa, S. Yoshioka, M. Murakami, H. Wada, S. Kobayashi, S. Marubashi, Y. Takeda, K. Dono, K. Umeshita, N. Matsuura, K. Matsubara, Y. Doki, M. Mori, M. Monden: Activation of Wnt/beta-catenin signalling pathway induces chemoresistance to interferon-alpha/5-fluorouracil combination therapy for hepatocellular carcinoma. Br J Cancer 100, 1647-58 (2009)
51. M. Munz, P. A. Baeuerle, O. Gires: The emerging role of EpCAM in cancer and stem cell signaling. Cancer Res 69, 5627-9 (2009)
52. P. Ruf, O. Gires, M. Jäger, K. Fellinger, J. Atz, H. Lindhofer: Characterisation of the new EpCAM-specific antibody HO-3: implications for trifunctional antibody immunotherapy of cancer. Br J Cancer 97, 315-21 (2007)
53. M. A. Grotzer, D. Castelletti, G. Fiaschetti, T. Shalaby, A. Arcaro: Targeting Myc in pediatric malignancies of the central and peripheral nervous system. Curr Cancer Drug Targets 9, 176-88 (2009)
54. J. Kota, R. R. Chivukula, K. A. O'Donnell, E. A. Wentzel, C. L. Montgomery, H. W. Hwang, T. C. Chang, P. Vivekanandan, M. Torbenson, K. R. Clark, J. R. Mendell, J. T. Mendell: Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 137, 1005-17 (2009)
55. E. M. Fatourou, J. S. Koskinas: Adaptive immunity in hepatocellular carcinoma: prognostic and therapeutic implications Expert Rev Anticancer Ther, 9(10), 1499-510 (2009)
56. Y. T. Siu, D. Y. Jin: CREB-a real culprit in oncogenesis. FEBS J 274, 3224-32 (2007)
57. C. Garrido, E. Schmitt, C. Candé, N. Vahsen, A. Parcellier, G. Kroemer: HSP27 and HSP70: potentially oncogenic apoptosis inhibitors. Cell Cycle 2, 579-84 (2003)
58. X. F. Zhao, R. B. Gartenhaus: Phospho-p70S6K and cdc2/cdk1 as therapeutic targets for diffuse large B-cell lymphoma. Expert Opin Ther Target 13, 1085-93 (2009)